These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29698625)

  • 1. Sphingolipids as targets for inhalation treatment of cystic fibrosis.
    Becker KA; Riethmüller J; Seitz AP; Gardner A; Boudreau R; Kamler M; Kleuser B; Schuchman E; Caldwell CC; Edwards MJ; Grassmé H; Brodlie M; Gulbins E
    Adv Drug Deliv Rev; 2018 Aug; 133():66-75. PubMed ID: 29698625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid Ceramidase Rescues Cystic Fibrosis Mice from Pulmonary Infections.
    Becker KA; Verhaegh R; Verhasselt HL; Keitsch S; Soddemann M; Wilker B; Wilson GC; Buer J; Ahmad SA; Edwards MJ; Gulbins E
    Infect Immun; 2021 Jan; 89(2):. PubMed ID: 33139382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis.
    Gardner AI; Wu Y; Verhaegh R; Liu Y; Wilker B; Soddemann M; Keitsch S; Edwards MJ; Haq IJ; Kamler M; Becker KA; Brodlie M; Gulbins E
    J Biol Chem; 2021; 296():100650. PubMed ID: 33839155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial Infections.
    Grassmé H; Henry B; Ziobro R; Becker KA; Riethmüller J; Gardner A; Seitz AP; Steinmann J; Lang S; Ward C; Schuchman EH; Caldwell CC; Kamler M; Edwards MJ; Brodlie M; Gulbins E
    Cell Host Microbe; 2017 Jun; 21(6):707-718.e8. PubMed ID: 28552668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
    Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.
    Gardner AI; Haq IJ; Simpson AJ; Becker KA; Gallagher J; Saint-Criq V; Verdon B; Mavin E; Trigg A; Gray MA; Koulman A; McDonnell MJ; Fisher AJ; Kramer EL; Clancy JP; Ward C; Schuchman EH; Gulbins E; Brodlie M
    Am J Respir Crit Care Med; 2020 Oct; 202(8):1133-1145. PubMed ID: 32569477
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of Sphingosine Causes Susceptibility to Pulmonary Staphylococcus Aureus Infections in Cystic Fibrosis.
    Tavakoli Tabazavareh S; Seitz A; Jernigan P; Sehl C; Keitsch S; Lang S; Kahl BC; Edwards M; Grassmé H; Gulbins E; Becker KA
    Cell Physiol Biochem; 2016; 38(6):2094-102. PubMed ID: 27184795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide and sphingosine in pulmonary infections.
    Seitz AP; Grassmé H; Edwards MJ; Pewzner-Jung Y; Gulbins E
    Biol Chem; 2015 Jun; 396(6-7):611-20. PubMed ID: 25720061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
    Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
    Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa.
    Pewzner-Jung Y; Tavakoli Tabazavareh S; Grassmé H; Becker KA; Japtok L; Steinmann J; Joseph T; Lang S; Tuemmler B; Schuchman EH; Lentsch AB; Kleuser B; Edwards MJ; Futerman AH; Gulbins E
    EMBO Mol Med; 2014 Sep; 6(9):1205-14. PubMed ID: 25085879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs.
    Kovacic B; Sehl C; Wilker B; Kamler M; Gulbins E; Becker KA
    Cell Physiol Biochem; 2017; 41(3):1208-1218. PubMed ID: 28427052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Development of Sphingosine as Anti-Bacterial Drug: Inhalation of Sphingosine in Mini Pigs has no Adverse Side Effects.
    Carstens H; Schumacher F; Keitsch S; Kramer M; Kühn C; Sehl C; Soddemann M; Wilker B; Herrmann D; Swaidan A; Kleuser B; Verhaegh R; Hilken G; Edwards MJ; Dubicanac M; Carpinteiro A; Wissmann A; Becker KA; Kamler M; Gulbins E
    Cell Physiol Biochem; 2019; 53(6):1015-1028. PubMed ID: 31854953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary infection of cystic fibrosis mice with Staphylococcus aureus requires expression of α-toxin.
    Keitsch S; Riethmüller J; Soddemann M; Sehl C; Wilker B; Edwards MJ; Caldwell CC; Fraunholz M; Gulbins E; Becker KA
    Biol Chem; 2018 Sep; 399(10):1203-1213. PubMed ID: 29613852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis.
    Yu H; Zeidan YH; Wu BX; Jenkins RW; Flotte TR; Hannun YA; Virella-Lowell I
    Am J Respir Cell Mol Biol; 2009 Sep; 41(3):367-75. PubMed ID: 19168701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis.
    Becker KA; Grassmé H; Zhang Y; Gulbins E
    Cell Physiol Biochem; 2010; 26(1):57-66. PubMed ID: 20502005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of sphingolipids in respiratory disease.
    Yang Y; Uhlig S
    Ther Adv Respir Dis; 2011 Oct; 5(5):325-44. PubMed ID: 21900155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
    Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
    Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis.
    Becker KA; Riethmüller J; Zhang Y; Gulbins E
    Open Respir Med J; 2010 Mar; 4():39-47. PubMed ID: 20556203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in
    Schiumarini D; Loberto N; Mancini G; Bassi R; Giussani P; Chiricozzi E; Samarani M; Munari S; Tamanini A; Cabrini G; Lippi G; Dechecchi MC; Sonnino S; Aureli M
    Mediators Inflamm; 2017; 2017():1730245. PubMed ID: 29333001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophils Kill Reactive Oxygen Species-Resistant Pseudomonas aeruginosa by Sphingosine.
    Becker KA; Li X; Seitz A; Steinmann J; Koch A; Schuchman E; Kamler M; Edwards MJ; Caldwell CC; Gulbins E
    Cell Physiol Biochem; 2017; 43(4):1603-1616. PubMed ID: 29040968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.